首页|2020-2023年某三级甲等综合性医院药品不良反应回顾性分析

2020-2023年某三级甲等综合性医院药品不良反应回顾性分析

扫码查看
目的 分析某三级甲等综合性医院2020-2023年药品不良反应(ADR)的发生特点和规律,识别高风险药物,降低临床用药风险,为临床合理用药提供参考。方法 采用回顾性分析方法,对温州市人民医院2020年1月至2023年12月收集上报的1 516例ADR报告进行汇总,从报告数量、报告者、ADR程度、患者性别、年龄、药品剂型、给药途径、药物类别、累及器官系统及转归等进行统计分析。结果 2022年ADR报告数量最多(484例);报告者以医生为主898例(59。23%);一般的ADR 968例(63。85%),新的/严重ADR 548例(36。15%),ADR报告类型在不同年份间分布差异有统计学意义(x2=12。397,P<0。05);ADR患者男女比例为1。05∶1,男性组中新的/严重ADR高于女性(x2=11。086,P<0。001);70岁以上患者所占比例最高(37。47%),新的/严重ADR比例也较其他年龄段高(x2=39。368,P<0。001);药品剂型以注射剂引起的ADR最多473例(44。92%);给药途径中以静脉滴注引起的ADR最多739例(48。75%);新的/严重的ADR涉及的剂型以注射剂为主230例(41。97%),给药途径以静脉给药为主249例(45。44%);抗感染药物引起的ADR最多452例(29。82%);其次是心血管系统药物283例(18。67%);抗感染药物引起的ADR中,以喹诺酮类最多215例次(47。57%),其次为β-内酰胺类169例(37。39%);心血管系统类药物引起的ADR中,抗血小板药最多106例(37。72%);ADR累及的系统/器官以皮肤及皮下组织异常为主290例(19。13%),新的/严重主要表现为全身性反应、消化系统、心血管系统;94。29%的患者发生ADR后痊愈或好转。结论 应进一步加强ADR监测工作,尤其特殊人群和高风险药物的用药监测,提高临床对ADR的应对处理能力,促进临床合理用药。
Retrospective analysis of adverse drug reactions in a level ⅢA hospital from 2020 to 2023
Objective To analyze the characteristics and patterns of adverse drug reactions(ADR)in level Ⅲ A general hospital from 2020 to 2023,identify high-risk drugs,reduce clinical medication risks,and provide reference for rational drug use in clinical practice.Methods Retrospective analysis was carried out on 1 516 ADR reports collected and reported in Wenzhou People's Hospital from January 2020 to December 2023,and statistical analysis was conducted from the report number,reporter,ADR degree,patient gender,age,drug dosage form,route of administration,drug category,organ system involved and outcome.Results The number of ADR reports in 2022 was the highest(484 cases).A total of 898 cases(59.23%)were mainly doctors.There were 968 cases(63.85%)of general ADRs and 548 cases(36.15%)of new/severe ADRs.There were significant differences in the distribution of ADR report types among different years(x2=12.397,P<0.05).The ratio of male to female ADR patients was 1.05∶1,and new/serious ADR in male group was slightly higher than that in female group(x2=11.086,P<0.001).The proportion of patients over 70 years old was the highest(37.47%),and the proportion of new/serious ADR was also higher than that of other age groups(x2=39.368,P<0.001).The number of ADR caused by injection was 473(44.92%).Up to 739 ADR cases(48.75%)were caused by intravenous infusion.The dosage forms of new/serious ADRs were mainly injection in 230 cases(41.97%),and intravenous administration in 249 cases(45.44%).The number of ADR cases caused by anti-infective drugs was 452(29.82%).Followed by cardiovascular system drugs 283 cases(18.67%);Among the ADRs caused by anti-infective drugs,quinolones accounted for the most 215 cases(47.57%),followed by β-lactam 169 cases(37.39%).Among the ADRs caused by cardiovascular drugs,antiplatelet drugs were 106(37.72%).The system/organs involved in ADR were mainly skin and subcutaneous tissue abnormalities in 290 cases(19.13%),and the new/severe ADR mainly showed physical reaction,digestive system and cardiovascular system.94.29%of the patients recovered or improved after ADR.Conclusion ADR monitoring should be further strengthened,especially for special populations and high-risk drugs,so as to improve clinical response to deal with ADR and promote clinical rational drug use.

Drug-related side effects and adverse reactionsMonitorRetrospective analysisHospitalsSafe medication

李好、江静静、吴超贤

展开 >

温州市人民医院公共卫生科,浙江温州 325000

温州市人民医院药剂科,浙江温州 325000

药物相关性副作用和不良反应 监测 回顾性分析 医院 安全用药

浙江省温州市基础性科研项目

Y20210380

2024

中国药物与临床
中国医院协会

中国药物与临床

影响因子:0.846
ISSN:1671-2560
年,卷(期):2024.24(14)